Email this article Colon cancer-induced sarcopenia: clinical and radiological correlations
- Authors: Lyadov V.K.1,2,3, Fedorinov D.S.1,2, Lyadova M.A.1,3, Khristenko E.A.4, Boldyreva T.S.1, Galkin V.N.1
-
Affiliations:
- Moscow State Budgetary Healthcare Institution "Moscow City Oncological Hospital No.1, Moscow Healthcare Department"
- Russian Medical Academy of Continuous Professional Education
- Novokuznetsk State Institute for the Advanced Training of Doctors – branch of the Russian Medical Academy of Continuous Professional Education
- RNS Radiology аnd Radiotherapy
- Issue: Vol 25, No 3 (2023)
- Pages: 278-282
- Section: НУТРИТИВНАЯ ПОДДЕРЖКА В КЛИНИЧЕСКОЙ ОНКОЛОГИИ
- URL: https://bakhtiniada.ru/1815-1434/article/view/148887
- DOI: https://doi.org/10.26442/18151434.2023.3.202447
- ID: 148887
Cite item
Full Text
Abstract
Background. The course of colon cancer (CC) is burdened in many patients with elderly and senile age, the presence of severe comorbidities, and complications of the malignancy. The complex treatment for advanced colon tumors also requires the search for predictors appropriate for routine clinical practice.
Aim. To study the prevalence of sarcopenia (SP) in CC and assess the relationship of SP with the immediate treatment outcomes.
Materials and methods. A retro-prospective assessment of cachexia and SP according to clinical and radiological criteria and their relationship to postoperative complications was performed in 679 patients. The mean age was 65±10.7 years. Group 1 included 181 patients who received drug therapy for common types of CC. Group 2 included 498 patients who underwent elective colon resections for cancer. The presence of SP was determined by threshold values for skeletal muscle area at the LIII level, averaged to the patient's height squared. To do this, the data from abdominal computed tomography performed for 1 month or less before the start of antitumor treatment were analyzed. The threshold criteria of Prado, Martin, and the European Working Group on Sarcopenia in Older People (EWGSOP2) were compared.
Results. The SP prevalence was 64% according to the Prado criteria for stages I–II, 66% for stage III, and 73.4% for stage IV; according to the Martin criteria, 63.1%, 62.3%, and 68%, respectively, and according to the EWGSOP2 criteria 22.7%, 26.9%, and 32%, respectively. In general, SP was noted according to the Prado criteria in 70.2% of men and 61.4% of women, according to the Martin criteria in 55.8% of men and 71.9% of women, and according to the EWGSOP2 criteria in 27% of men and 22.9% of women. Sarcopenic obesity was identified in 10.1% of patients. In group 1, there was a statistically significant correlation (p<0.001) between the presence of SP and poor overall survival of patients, with the Martin criteria showing the most significant correlation. In group 2, an equally strong correlation between the presence of SP according to the Prado criteria and postoperative mortality was found.
Conclusion. In CC, SP is detected in more than half of patients before the start of antitumor treatment, being an unfavorable prognostic factor for overall survival and a predictor of death after surgical treatment. Timely diagnosis and treatment of SP can improve the CC therapy outcome.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir K. Lyadov
Moscow State Budgetary Healthcare Institution "Moscow City Oncological Hospital No.1, Moscow Healthcare Department"; Russian Medical Academy of Continuous Professional Education; Novokuznetsk State Institute for the Advanced Training of Doctors – branch of the Russian Medical Academy of Continuous Professional Education
Author for correspondence.
Email: vlyadov@gmail.com
ORCID iD: 0000-0002-7281-3591
d. sci. (med.)
Russian Federation, Moscow; NovokuznetskDenis S. Fedorinov
Moscow State Budgetary Healthcare Institution "Moscow City Oncological Hospital No.1, Moscow Healthcare Department"; Russian Medical Academy of Continuous Professional Education
Email: deni_fe@mail.com
ORCID iD: 0000-0001-5516-7367
oncologist
Russian Federation, MoscowMarina A. Lyadova
Moscow State Budgetary Healthcare Institution "Moscow City Oncological Hospital No.1, Moscow Healthcare Department"; Novokuznetsk State Institute for the Advanced Training of Doctors – branch of the Russian Medical Academy of Continuous Professional Education
Email: dr.lyadova@gmail.com
ORCID iD: 0000-0002-9558-5579
cand. sci. (med.)
Russian Federation, Moscow; NovokuznetskEkaterina A. Khristenko
RNS Radiology аnd Radiotherapy
Email: e.khristenko@rns-wiesbaden.de
ORCID iD: 0000-0003-2611-5204
cand. sci. (med.)
Germany, Bad SodenTatyana S. Boldyreva
Moscow State Budgetary Healthcare Institution "Moscow City Oncological Hospital No.1, Moscow Healthcare Department"
Email: dikovatatyanasergeevna@gmail.com
ORCID iD: 0000-0003-4174-6637
oncologist
Russian Federation, MoscowVsevolod N. Galkin
Moscow State Budgetary Healthcare Institution "Moscow City Oncological Hospital No.1, Moscow Healthcare Department"
Email: vsgalkin@gmail.com
ORCID iD: 0000-0002-6619-6179
d. sci. (med.), prof.
Russian Federation, MoscowReferences
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49. doi: 10.3322/caac.21660
- Состояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022 [Sostoianie onkologicheskoi pomoshchi naseleniiu Rossii v 2021 godu. Pod red. AD Kaprina, VV Starinskogo, AO Shakhzadovoi. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITs radiologii» Minzdrava Rossii, 2022 (in Russian)].
- Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 2011;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7
- Trejo-Avila M, Bozada-Gutiérrez K, Valenzuela-Salazar C, et al. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: A systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(6):1077-96. doi: 10.1007/s00384-021-03839-4. PMID: 33481108
- Malietzis G, Currie AC, Athanasiou T, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103(5):572-80. doi: 10.1002/bjs.10075
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al.; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi: 10.1093/ageing/afy169
- Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997-1006. doi: 10.1139/H08-075
- Лядов В.К., Егиев В.Н., Серяков А.П., и др. Саркопения и распределение жировой ткани у пациентов с колоректальным раком. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2012;3:33-7 [Lyadov VK, Yegiyev VN, Seryakov AP, et al. Sarcopenia and fat tissue distribution in patients with colorectal cancer. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2012;3:33-7 (in Russian)].
- Лядов В.К., Кочатков А.В., Негардинов А.З. Влияние стандартизированного протокола ускоренного выздоровления на результаты радикальных резекций толстой кишки у больных старческого возраста. Колопроктология. 2017;(3):40-4 [Lyadov VK, Kochatkov AV, Negardinov AZ. Standardized enhanced recovery protocol improves outcomes after colorectal resections in elderly patients. Koloproktologia. 2017;(3):40-4 (in Russian)]. doi: 10.33878/2073-7556-2017-0-3-40-44
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae
- Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 2008;9(7):629-35. doi: 10.1016/S1470-2045(08)70153-0
- Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539-47. doi: 10.1200/JCO.2012.45.2722
- van der Werf A, Langius JAE, de van der Schueren MAE, et al. Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population. Eur J Clin Nutr. 2018;72(2):288-96. doi: 10.1038/s41430-017-0034-5
- Itatani Y, Kawada K, Sakai Y. Treatment of elderly patients with colorectal cancer. Biomed Res Int. 2018;2018:2176056. doi: 10.1155/2018/2176056
- van Vugt JL, Braam HJ, van Oudheusden TR, et al. Skeletal muscle depletion is associated with severe post-operative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2015;22(11):3625-31. doi: 10.1245/s10434-015-4429-z
- Reisinger KW, van Vugt JLA, Tegels JJW, et al. Functional compromise reflected by sarcopenia, frailty and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2015;261(2):345-52. doi: 10.1097/SLA.0000000000000628
Supplementary files
